Asia Pacific Lithotripsy Market Forecast to 2031 - Regional Analysis - by Product Type (Extracorporeal Shock Wave Lithotripsy Devices, Intracorporeal Lithotripsy Devices, and Ureteroscopic), Application (Kidney Stones, Ureteral Stones, Pancreatic Stones,

The Asia Pacific lithotripsy market was valued at US$ 235.12 million in 2023 and is expected to reach US$ 419.89 million by 2031; it is estimated to register a CAGR of 7.5% from 2023 to 2031.

Rise in Mobile Lithotripsy Services Fuels Asia Pacific Lithotripsy Market

Mobile lithotripsy medical units, commercial tractor-trailers, and coaches are significantly beneficial to patients. These units offer patients a new healthcare service without any requirement to set up a specialized lithotripsy center or additional investment. Patients' experience with mobile lithotripsy services is significantly improving with technological advancements. For example, in June 2021, Mobile Medical announced launching its new state-of-the-art mobile lithotripsy unit. The lithotripter device was successfully removed from the existing lithotripsy center and installed in a cab/mobile truck. Similarly, The Oklahoma Mobile Lithotripsy Associates (OMLA), a subsidiary of Oklahoma Lithotripter Associates, has continued to provide extracorporeal shockwave lithotripsy (ESWL) services to area hospitals through a lithotripsy bus/trailer since 1995. The service began with a single Dornier unit. However, with a rise in technological advancements, the units are now transported to each location in small vans, making accessibility and scheduling noninvasive lithotripsy procedures much more accessible. Currently, mobile lithotripsy service is only available in developed countries, particularly in the US, and is anticipated to grow in other countries in the future if awareness about mobile lithotripsy service is increased worldwide. Thus, the rise in mobile lithotripsy services is anticipated to create lucrative opportunities for the lithotripsy service providers in the market in the coming years.

Asia Pacific Lithotripsy Market Overview

According to the AME Publishing Company report, urolithiasis is one of the most prevalent diseases in China, with patients suffering from upper urinary stones. With high prevalence and recurrence rates, urolithiasis represents a major burden on the healthcare system in the country. Therefore, with the rising prevalence of urolithiasis, there is a high demand for extracorporeal shockwave lithotripsy (ESWL). ESWL is an advanced treatment device that has been widely adopted by doctors and patients in hospitals. Additionally, there are many hospitals in China where more than 5,000 cases annually have been treated with urolithiasis, as per the Chinese Medical Association Publishing House report. Furthermore, in a few hospitals, over 10 cases were treated in one day, and ~3,000 cases every year. Therefore, the rising prevalence of urolithiasis and the high adoption of lithotripsy in hospitals are a few factors responsible for the market growth in China.

Asia Pacific Lithotripsy Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Lithotripsy Market Segmentation

The Asia Pacific lithotripsy market is categorized into product type, application, end user, and country.

By product type, the Asia Pacific lithotripsy market is segmented into extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices, and ureteroscopic. The extracorporeal shock wave lithotripsy devices segment held the largest share of the Asia Pacific lithotripsy market share in 2023.

In term of application, the Asia Pacific lithotripsy market is segmented into kidney stones, ureteral stones, pancreatic stones, bile duct stones, and bladder stones. The kidney stones segment held the largest share of the Asia Pacific lithotripsy market share in 2023.

Based on end user, the Asia Pacific lithotripsy market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the Asia Pacific lithotripsy market share in 2023.

Based on country, the Asia Pacific lithotripsy market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China segment held the largest share of Asia Pacific lithotripsy market in 2023.

Becton Dickinson and Co, Boston Scientific Corp, Cook Medical Holdings LLC, DirexGroup, Dornier MedTech, Edap Tms SA, ELMED Medical Systems, EMS Electro Medical Systems SA (EMS+), Karl Storz SE & Co KG, NOVAmedtk, Olympus Corp, and Potent Medical are some of the leading companies operating in the Asia Pacific lithotripsy market.

Reasons to buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific lithotripsy market.
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific lithotripsy market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific lithotripsy market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.